Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more
Boiron SA (BOI) - Net Assets
Latest net assets as of June 2025: €369.12 Million EUR
Based on the latest financial reports, Boiron SA (BOI) has net assets worth €369.12 Million EUR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€561.59 Million) and total liabilities (€192.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €369.12 Million |
| % of Total Assets | 65.73% |
| Annual Growth Rate | 5.15% |
| 5-Year Change | -25.73% |
| 10-Year Change | -9.1% |
| Growth Volatility | 14.76 |
Boiron SA - Net Assets Trend (2001–2024)
This chart illustrates how Boiron SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Boiron SA (2001–2024)
The table below shows the annual net assets of Boiron SA from 2001 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €378.18 Million | -3.40% |
| 2023-12-31 | €391.50 Million | -29.76% |
| 2022-12-31 | €557.35 Million | +4.81% |
| 2021-12-31 | €531.77 Million | +4.44% |
| 2020-12-31 | €509.17 Million | +0.73% |
| 2019-12-31 | €505.46 Million | +4.00% |
| 2018-12-31 | €486.04 Million | -6.08% |
| 2017-12-31 | €517.49 Million | +10.20% |
| 2016-12-31 | €469.60 Million | +12.87% |
| 2015-12-31 | €416.04 Million | +9.52% |
| 2014-12-31 | €379.88 Million | -3.06% |
| 2013-12-31 | €391.86 Million | +10.64% |
| 2012-12-31 | €354.16 Million | -3.93% |
| 2011-12-31 | €368.65 Million | +7.21% |
| 2010-12-31 | €343.84 Million | +9.76% |
| 2009-12-31 | €313.28 Million | +15.39% |
| 2008-12-31 | €271.49 Million | +8.62% |
| 2007-12-31 | €249.94 Million | +8.63% |
| 2006-12-31 | €230.09 Million | +0.09% |
| 2005-12-31 | €229.88 Million | +59.54% |
| 2004-12-31 | €144.09 Million | -3.64% |
| 2003-12-31 | €149.53 Million | +11.20% |
| 2002-12-31 | €134.47 Million | +12.84% |
| 2001-12-31 | €119.17 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Boiron SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 191.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €231.83 Million | 61.31% |
| Common Stock | €17.55 Million | 4.64% |
| Other Comprehensive Income | €56.29 Million | 14.89% |
| Other Components | €72.48 Million | 19.17% |
| Total Equity | €378.14 Million | 100.00% |
Boiron SA Competitors by Market Cap
The table below lists competitors of Boiron SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Naintech Co. Ltd.
KQ:267320
|
$92.93 Million |
|
Rivco Australia Ltd
AU:RIV
|
$92.93 Million |
|
Lang Inc
TW:6165
|
$92.93 Million |
|
CELTIC PLC LS 001
F:CCP
|
$92.97 Million |
|
Singatron Enterprise Co Ltd
TWO:6126
|
$92.90 Million |
|
Fiera Milano S.p.A.
LSE:0EGH
|
$92.87 Million |
|
Paiho Shih Holdings Corp
TW:8404
|
$92.78 Million |
|
Fonar Corporation
NASDAQ:FONR
|
$92.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Boiron SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 393,661,000 to 378,145,000, a change of -15,516,000 (-3.9%).
- Net income of 11,336,000 contributed positively to equity growth.
- Dividend payments of 23,439,000 reduced retained earnings.
- Share repurchases of 206,000 reduced equity.
- Other comprehensive income decreased equity by 14,767,000.
- Other factors increased equity by 11,560,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €11.34 Million | +3.0% |
| Dividends Paid | €23.44 Million | -6.2% |
| Share Repurchases | €206.00K | -0.05% |
| Other Comprehensive Income | €-14.77 Million | -3.91% |
| Other Changes | €11.56 Million | +3.06% |
| Total Change | €- | -3.94% |
Book Value vs Market Value Analysis
This analysis compares Boiron SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.04x to 1.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-12-31 | €6.40 | €25.85 | x |
| 2002-12-31 | €7.23 | €25.85 | x |
| 2003-12-31 | €8.04 | €25.85 | x |
| 2004-12-31 | €7.74 | €25.85 | x |
| 2005-12-31 | €11.32 | €25.85 | x |
| 2006-12-31 | €10.50 | €25.85 | x |
| 2007-12-31 | €11.48 | €25.85 | x |
| 2008-12-31 | €12.46 | €25.85 | x |
| 2009-12-31 | €14.53 | €25.85 | x |
| 2010-12-31 | €16.01 | €25.85 | x |
| 2011-12-31 | €17.17 | €25.85 | x |
| 2012-12-31 | €16.63 | €25.85 | x |
| 2013-12-31 | €20.17 | €25.85 | x |
| 2014-12-31 | €19.70 | €25.85 | x |
| 2015-12-31 | €22.55 | €25.85 | x |
| 2016-12-31 | €25.48 | €25.85 | x |
| 2017-12-31 | €28.08 | €25.85 | x |
| 2018-12-31 | €27.32 | €25.85 | x |
| 2019-12-31 | €28.86 | €25.85 | x |
| 2020-12-31 | €29.08 | €25.85 | x |
| 2021-12-31 | €30.36 | €25.85 | x |
| 2022-12-31 | €32.07 | €25.85 | x |
| 2023-12-31 | €22.67 | €25.85 | x |
| 2024-12-31 | €21.78 | €25.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Boiron SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.33%
- • Asset Turnover: 0.85x
- • Equity Multiplier: 1.52x
- Recent ROE (3.00%) is below the historical average (12.65%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | 16.54% | 7.39% | 1.29x | 1.73x | €7.79 Million |
| 2002 | 17.13% | 8.02% | 1.24x | 1.72x | €9.58 Million |
| 2003 | 17.15% | 8.39% | 1.23x | 1.66x | €10.69 Million |
| 2004 | 14.30% | 7.09% | 1.07x | 1.88x | €6.19 Million |
| 2005 | 7.15% | 4.54% | 0.85x | 1.86x | €-6.55 Million |
| 2006 | 4.46% | 2.57% | 0.97x | 1.79x | €-12.75 Million |
| 2007 | 10.88% | 6.25% | 1.01x | 1.72x | €2.20 Million |
| 2008 | 14.45% | 8.39% | 1.01x | 1.71x | €12.07 Million |
| 2009 | 19.13% | 11.38% | 1.01x | 1.67x | €28.58 Million |
| 2010 | 12.60% | 8.31% | 0.93x | 1.62x | €8.92 Million |
| 2011 | 11.47% | 8.07% | 0.89x | 1.59x | €5.42 Million |
| 2012 | 14.02% | 8.76% | 0.98x | 1.64x | €14.23 Million |
| 2013 | 21.04% | 13.33% | 0.93x | 1.70x | €43.23 Million |
| 2014 | 23.45% | 14.60% | 0.91x | 1.76x | €51.08 Million |
| 2015 | 17.77% | 12.16% | 0.87x | 1.67x | €32.34 Million |
| 2016 | 16.55% | 12.65% | 0.81x | 1.61x | €30.77 Million |
| 2017 | 15.12% | 12.67% | 0.77x | 1.55x | €26.50 Million |
| 2018 | 11.82% | 9.51% | 0.79x | 1.58x | €8.86 Million |
| 2019 | 8.04% | 7.29% | 0.73x | 1.51x | €-9.92 Million |
| 2020 | 5.15% | 5.10% | 0.66x | 1.54x | €-24.70 Million |
| 2021 | 5.37% | 6.27% | 0.59x | 1.45x | €-24.62 Million |
| 2022 | 8.01% | 8.36% | 0.68x | 1.42x | €-11.09 Million |
| 2023 | 9.10% | 7.26% | 0.84x | 1.50x | €-3.54 Million |
| 2024 | 3.00% | 2.33% | 0.85x | 1.52x | €-26.48 Million |
Industry Comparison
This section compares Boiron SA's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $1,186,858,333
- Average return on equity (ROE) among peers: 11.04%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Boiron SA (BOI) | €369.12 Million | 16.54% | 0.52x | $92.91 Million |
| Euroapi SAS (EAPI) | $1.11 Billion | -1.35% | 0.56x | $65.91 Million |
| Ipsen SA (IPN) | $2.13 Billion | 25.68% | 1.02x | $4.04 Billion |
| Vetoquinol (VETO) | $316.48 Million | 8.79% | 0.39x | $301.84 Million |